ARMM

Vesigen Highlights Data Demonstrating Directed Tropism of Non-Viral Delivery Platform at the 30th Annual Congress of the European Society of Gene & Cell Therapy

Retrieved on: 
Wednesday, October 25, 2023
Biotechnology, Health, Genetics, Science, Research, Gene editing, Delivery, RNA, Tropism, ARMM, Macrophage, Liver, ARMM Regional Legislative Assembly, Mouse, Cell, Gene, ESGCT, European Society of Gene and Cell Therapy, Genome, Biodistribution, Therapy, Vaccine

Data highlighted the first demonstration of cell type-specific targeting of ARMMs and functional delivery of base editing complexes across diverse human cell types.

Key Points: 
  • Data highlighted the first demonstration of cell type-specific targeting of ARMMs and functional delivery of base editing complexes across diverse human cell types.
  • The data were presented at the 30th Annual Congress of the European Society of Cell and Gene Therapy (ESGCT), taking place October 24-27 in Brussels, Belgium.
  • “The data we presented at ESGCT represent the first demonstration of directed tropism of our non-viral ARMMs delivery platform.
  • This important result expands upon the natural biodistribution of ARMMs and demonstrates that ARMMs can be engineered to selectively target cell types of interest,” said Paulash Mohsen, Chief Executive Officer at Vesigen.

Vesigen Highlights Non-Human Primate Biodistribution of Non-Viral Technology and Functional Delivery of Genome Editors In Vivo at the Cracking the Code: The Dawn of Nucleic Acid Medicines Meeting

Retrieved on: 
Thursday, October 19, 2023
Health, Genetics, Research, Pharmaceutical, Science, Biotechnology, Gene editing, Retinal pigment epithelium, Mouse, Dawn, RNA, ARMM, Histopathology, ARMM Regional Legislative Assembly, RPE, Disease, Cell death, Cytotoxicity, Therapy, Kupffer cell, Retina, Vaccine

Specifically, the Company presented new data demonstrating retinal biodistribution of engineered ARMMs across multiple species – including non-human primates – and data demonstrating successful in vivo functional delivery of a Cas9/guide RNA gene editing complex.

Key Points: 
  • Specifically, the Company presented new data demonstrating retinal biodistribution of engineered ARMMs across multiple species – including non-human primates – and data demonstrating successful in vivo functional delivery of a Cas9/guide RNA gene editing complex.
  • The data were presented at the Cracking the Code: The Dawn of Nucleic Acid Medicines meeting, taking place October 17-19, 2023, in Worcester, MA.
  • “We have shown that our ARMM technology can successfully deliver functionally active gene editing complexes to Kupffer cells and ameliorate disease in an acute liver injury model.
  • Additional data in mice, minipigs, and non-human primates demonstrated the efficient delivery of subretinally administered ARMMs to the RPE and photoreceptors, cell types associated with multiple retinal diseases.

Vesigen Highlights New Data on Non-Viral Delivery Platform at the Exosome Based Therapeutic Development Summit

Retrieved on: 
Thursday, September 7, 2023
Science, Other Science, Biotechnology, Research, Pharmaceutical, Health, Genetics, Other Health, Delivery, Gene editing, ARMM, Therapy, Exosome, RNA, Annual general meeting, Vaccine

Vesigen Therapeutics, Inc., a biotechnology company developing a novel non-viral delivery platform for gene editors, RNA, and protein-based therapeutics, today showcased new data at the Exosome Based Therapeutic Development Summit 5th Annual Meeting held September 5-7, 2023 in Boston.

Key Points: 
  • Vesigen Therapeutics, Inc., a biotechnology company developing a novel non-viral delivery platform for gene editors, RNA, and protein-based therapeutics, today showcased new data at the Exosome Based Therapeutic Development Summit 5th Annual Meeting held September 5-7, 2023 in Boston.
  • The presentation highlighted new data on the company’s proprietary ARMM (ARrestin-domain 1 Mediated Microvesicles) delivery technology, including therapeutic in vivo gene editing in a preclinical model of acute liver injury, and summarized biodistribution translation evidence generated across species, including non-human primates.
  • Details of the oral presentation are as follows:
    Engineered ARMMs for Delivery of Therapeutic Payloads.
  • Joseph Nabhan, Ph.D., Chief Scientific Officer, Vesigen Therapeutics.

Vesigen Highlights Therapeutic Platform for Non-Viral Delivery of Gene Editors and RNA at ASGCT 2023

Retrieved on: 
Monday, May 22, 2023
Research, Neurology, Genetics, Stem Cells, Biotechnology, Other Health, Health, Pharmaceutical, Science, Retina, GMP, Tissue, CRISPR, Broad Institute, Therapy, Gene, Macrophage, Intrinsic termination, Harvard University, Engineering, Tag (metadata), NLRP3, Cell, RNA, Messenger, Lung, ARMM, Spleen, Annual general meeting, IRF5, Liver, ARMM Regional Legislative Assembly, Society, Office of the Gene Technology Regulator, Peripheral nervous system, Vaccine, Medical imaging, Fine chemical, Adenine

Vesigen Therapeutics, Inc., a biotechnology company developing a novel non-viral delivery platform for gene editors, RNA, and protein-based therapeutics, showcased eight data presentations at the American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting held May 16-20, 2023 in Los Angeles.

Key Points: 
  • Vesigen Therapeutics, Inc., a biotechnology company developing a novel non-viral delivery platform for gene editors, RNA, and protein-based therapeutics, showcased eight data presentations at the American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting held May 16-20, 2023 in Los Angeles.
  • “Based on the substantial evidence generated to date, we believe our approach enables highly efficient, tunable, and re-dosable delivery of multiple emerging therapeutic modalities.
  • In mouse models, functional delivery of engineered ARMMs was observed in the retina, lung, spleen, liver, and other tissues.
  • Three data presentations, including collaborations with Lonza Cell and Gene Technologies and NanoFCM, highlighted development of scalable approaches to produce and characterize ARMMs.

Tolam Earth Announces Open Sourcing of Carbon Offset Marketplace Components

Retrieved on: 
Wednesday, December 14, 2022
Maker, Learning, GitHub, Ecosystem, Investment, API, Machine learning, Hashgraph, ARMM, Carbon, Renewable energy, Cryptocurrency, Hedera

The marketplace will simplify the learning required for corporations to make large, secure purchase decisionsin order to meet their carbon reduction, carbon neutrality, or net zero goals.

Key Points: 
  • The marketplace will simplify the learning required for corporations to make large, secure purchase decisionsin order to meet their carbon reduction, carbon neutrality, or net zero goals.
  • Tolam has now open sourced its:
    Tolam's mission encourages collaboration to bring sustainability leaders and project developers into the future together.
  • "It has been our vision to open source our codebase to help ensure our platform meets the needs of the growing carbon market.
  • Tolam Earth is a digital marketplace to identify, price, buy, and sell carbon assets.

Tolam Earth Announces New Marketplace and Automated Regression Market Maker (TM) to Deliver Enterprise Scale Carbon Offset Buying and Selling

Retrieved on: 
Tuesday, November 8, 2022
Hashgraph, Fraud, ESG, Apple Computer, Inc. v. Franklin Computer Corp., Trust, Ecosystem, Policy, ARMM, Learning, Carbon, ARMM Regional Legislative Assembly, Goal, Investment, Technology, Cryptocurrency, Online shopping

Tolam Earth's technology transparently documents the life cycle of carbon credits, which reduce fraud in the ESG market.

Key Points: 
  • Tolam Earth's technology transparently documents the life cycle of carbon credits, which reduce fraud in the ESG market.
  • Tolam is opening a new world of possibilities by tying the technology of automated market makers to real world variable assets represented on-chain.
  • Tolam Earth is a digital marketplace to identify, price, buy, and sell carbon assets.
  • With the price discovery and auto-purchasing mechanisms of Tolam, we drive optimal liquidity and pricing to all market participants.

ARMM Enters into Business Combination with Current Energy and Renewables Corp.

Retrieved on: 
Thursday, August 18, 2022
Wind, Intellectual property, IOC, Electric Bond and Share Company v. Securities and Exchange Commission, CER, CEO, IP, SEC, USD, History, Professional, NewCo, Government, Public utilities commission, Natural Currents Energy Services, Mitsubishi Corporation, SELF, Letter, ARMM, Company, Pacific Rubiales Colombia Classic, Firearm, Safety, Ministry of Basic, Higher and Technical Education (Bangsamoro), Electricity, Constellation (energy company), OTCQB, California Public Utilities Commission, PNG, Clarion, Nasdaq, Solution, ExxonMobil, Renewable energy, Holding company, Marketing

DALLAS, Aug. 18, 2022 /PRNewswire/ -- ARMM Inc. (OTCQB: ARMM) (the "Company" or "ARMM") announced today that it has entered into a binding letter of intent withCurrent Energy and Renewables Corp.("CER") a supplier of renewable and traditional energy to commercial and industrial clients in deregulated markets.

Key Points: 
  • DALLAS, Aug. 18, 2022 /PRNewswire/ -- ARMM Inc. (OTCQB: ARMM) (the "Company" or "ARMM") announced today that it has entered into a binding letter of intent withCurrent Energy and Renewables Corp.("CER") a supplier of renewable and traditional energy to commercial and industrial clients in deregulated markets.
  • Mark Lawson, Armm's Chief Executive Officer, stated, "Our existing shareholder base has deep expertise within the full energy spectrum.
  • Sustainability and renewable energy is a key part of the energy transition story at a juncture where we are at the doorstep of a global energy crisis."
  • The Current Energy and Renewables team boasts over 40 years of experience in the international energy industry and is focused on streamlining all components of energy supply.

ARMM To Host American Tactical Defense MAGLITE® Sponsored Active Shooter School Training Webinar on June 22nd

Retrieved on: 
Friday, June 17, 2022
Federal Law Enforcement Training Centers, Safety, School, Self-Reliance, Checklist, OTCQB, Web conferencing, EST, Program, SELF, ARMM, American Federation of School Administrators, History, Federal law, COO, U.S. Coast Guard environmental protection, Federal, Firearm, Tutoring, Gunsmith

DALLAS, June 17, 2022 /PRNewswire/ --ARMM Inc. (OTCQB: ARMM) (the "Company" or "ARMM")a firearms lifestyle platform focused on Self-Reliance, is pleased to announce that on Wednesday, June 22, 2022 at 2pm EST / 11am PST, ARMM and American Tactical Defense will be hosting an Active Shooter School Training Live Webinar, at the Maglite Campus in Ontario, California.

Key Points: 
  • DALLAS, June 17, 2022 /PRNewswire/ --ARMM Inc. (OTCQB: ARMM) (the "Company" or "ARMM")a firearms lifestyle platform focused on Self-Reliance, is pleased to announce that on Wednesday, June 22, 2022 at 2pm EST / 11am PST, ARMM and American Tactical Defense will be hosting an Active Shooter School Training Live Webinar, at the Maglite Campus in Ontario, California.
  • To register for the event, please use the following link: https://www.eventbrite.com/e/368694002687
    Teachers that participate in the Webinar will receive a free copy of the Teachers Pocket Guide to Active Shooter Response, and School Administrators will receive the School Threat Assessment Checklist.
  • American Tactical Defense is certified under the Schools A.C.T.
  • He wrote the book on Federal active shooter response and training and currently keeps it up to date.

ARMM Offers Teachers the American Tactical Defense MAGLITE® Sponsored Active Shooter School Training

Retrieved on: 
Thursday, June 9, 2022
Company, Firearm, Program, School, ARMM, COO, CEO, Checklist, ATD, SELF, American Federation of School Administrators, Web conferencing, U.S. Coast Guard environmental protection, History, Federal, Education, Federal Law Enforcement Training Centers, Federal law, Safety, Gunsmith

In the coming weeks, ARMM and American Tactical Defense will be hosting an Active Shooter School Training Live Webinar, at the Maglite Campus in Ontario, California.

Key Points: 
  • In the coming weeks, ARMM and American Tactical Defense will be hosting an Active Shooter School Training Live Webinar, at the Maglite Campus in Ontario, California.
  • Teachers that participate in the Webinar will receive a free copy of the Teachers Pocket Guide to Active Shooter Response, and School Administrators will receive the School Threat Assessment Checklist.
  • "Now more than ever, given our mission of self reliance, firearms education and training, situational awareness has become paramount.
  • He wrote the book on Federal active shooter response and training and currently keeps it up to date.

ARMM Appoints Industry Veteran Jacob Herman to the Board of Directors

Retrieved on: 
Monday, May 9, 2022
Board, COVID-19, Board of directors, WSF, Kinetics, Woman, Safari Club International, Company, Blackwater (company), National Shooting Sports Foundation, Firearm, Safety, Self-Reliance, Middle Tennessee State University, Program, SCI, Industry, OTCQB, SELF, Google Play, NSSF, Radio, NRA, ARMM, App Store (iOS/iPadOS), CEO, Century International Arms, Hunting, Agribusiness

DALLAS, May 9, 2022 /PRNewswire/ -- ARMM Inc.(OTCQB: ARMM) (the "Company" or "ARMM")a firearms lifestyle platform focused on Self-Reliance, is pleased to announce the appointment of Jacob Herman to the Company's Board of Directors, effective immediately.

Key Points: 
  • DALLAS, May 9, 2022 /PRNewswire/ -- ARMM Inc.(OTCQB: ARMM) (the "Company" or "ARMM")a firearms lifestyle platform focused on Self-Reliance, is pleased to announce the appointment of Jacob Herman to the Company's Board of Directors, effective immediately.
  • Prior to joining the Blackwater Worldwide management team, Mr. Herman founded the very successfulconsulting firm in the outdoor space where he built a deep knowledge of the shooting industry.
  • Mark Lawson, Founder and CEO of ARMM, said, "We are honored and excited to welcome Jacob to our team.
  • With a majority of firearm related processes still paper based, ARMM feels the industry is ripe for technological disruption.